Diatiro
Diatiro is pioneering novel therapies to treat type 1 and type 2 diabetes and Alzheimer’s disease by repurposing approved medications and employing new chemical entities to protect beta cells and neurons, and prevent disease progression.
Veradermics
Veradermics is a rapidly growing aesthetics and dermatology focused biopharma with a large patent portfolio and 3 late stage products for baldness in men and women, alopecia aerata, and common warts.
Somnum Pharma
Somnum Pharma is developing the next generation of therapy for chronic insomnia.
ConnectRN
ConnectRN is the leading mobile platform providing nurses with flexible work opportunities across healthcare settings.
Leal Therapeutics
Developing novel therapeutics for patients with major disorders of the central nervous system
Ajna BioSciences
Ajna BioSciences is a botanical drug development company focused on full-spectrum cannabinoid and natural psychedelic options for mental health and neurological disorders.
Epitor Therapeutics
Epitor Therapeutics is an epigenetic editing company focused on developing novel tools to regulate gene expression that is under epigenetic control.
Switch Therapeutics
Switch is developing precision medicines for central nervous system (CNS) diseases with high unmet need.
Blackrock Neurotech
Blackrock Neurotech’s Brain-Computer Interface (BCI) restores patients’ ability to move, communicate, and interact with their surroundings. The neuromodulation application is developing therapies for epilepsy and psychiatric disorders.
Cirsium Biosciences
Cirsium Biosciences focuses on AAV production for plant based manufacturing, offering a modular, cost-effective, and customizable alternative to mammalian cells.